Long-term outcomes for patients with aneurysmal subarachnoid hemorrhage
Long-term Prognosis of Emergency Aneurysmal Subarachnoid Hemorrhage: an MDT- Based Multicenter Cohort Study
This study looks at how well different treatments for aneurysmal subarachnoid hemorrhage work over the long term for patients who have had this condition.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 5000 (estimated) |
| Sex | All |
| Sponsor | Beijing Tiantan Hospital Academic / other |
| Locations | 2 sites (Beijing, Beijing Municipality and 1 other locations) |
| Trial ID | NCT04785976 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the long-term prognosis of patients who experience aneurysmal subarachnoid hemorrhage (aSAH). It focuses on understanding the effectiveness of surgical clipping and endovascular coiling as treatment options while considering individual patient differences. By collecting data from patients admitted to emergency departments, the study seeks to improve diagnosis, treatment efficiency, and ultimately reduce mortality and healthcare costs associated with aSAH. The findings may also pave the way for interdisciplinary clinical practices and further scientific research.
Who should consider this trial
Good fit: Ideal candidates for this study are patients admitted to the emergency department with a diagnosis of aneurysmal subarachnoid hemorrhage.
Not a fit: Patients who do not have aneurysmal subarachnoid hemorrhage will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment strategies and better long-term outcomes for patients suffering from aneurysmal subarachnoid hemorrhage.
How similar studies have performed: While there have been studies on aSAH treatment outcomes, this specific observational approach focusing on long-term prognosis is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients admitted to the emergency department of the investigator with aneurysmal subarachnoid hemorrhage are included in their prospective registry. Exclusion Criteria: * None
Where this trial is running
Beijing, Beijing Municipality and 1 other locations
- Beijing Tiantan Hospital — Beijing, Beijing Municipality, China (Recruiting)
- The First People's Hospital of Neijiang — Neijiang, Sichuan, China (Recruiting)
Study contacts
- Principal investigator: Fa Lin, MD — Beijing Tiantan Hospital
- Study coordinator: Runting Li, MD
- Email: 1011168227@qq.com
- Phone: +8615753166690
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.